Cell Therapy In Cardiovascular Disease (CVD)
- Cell therapy offers transformative potential for treating CVD by regenerating heart tissue and improving function
- Our pharma client sought an examination of the clinical landscape, including key players, trials, market trends, challenges, and future outlook
- The goal was to provide an in-depth understanding of how stem cell therapy can be a promising treatment for CVD and its clinical landscape
- Secondary Research: Analyzed different types of cell therapy for CVD, key players in cell therapy through online literature available in various journals, clinical trials and webpages like NIH, Centre for Regenerative Medicine, BOOST 2, REPEAT-AMI etc.
- – Conducted extensive data interpretation for market size and growth, investment and funding along with regulatory landscape for these therapies
- Primary Research: To corroborate the information derived from secondary sources, we conducted in-depth qual interviews with cardiologists and patient advocacy groups to validate and gain a deeper understanding of the current landscape of stem cell therapies for cardiovascular disease
- Effectively identified the challenges associated with safety and efficacy, as well as cost and accessibility, for the client
- Provided valuable insights into future advancements and global expansion, aiding in the understanding of emerging markets for regenerative therapies
